Home LiteratureArticle Details
PMID: 21940625 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

The Journal of biological chemistry ·Vol. 286 ·No. 46 ·2011-11-18 ·Pages 39993-40001

Toledo D, Ramon E, Aguilà M, Cordomí A, Pérez JJ, Mendes HF, Cheetham ME, Garriga P

Abstract

Two different mutations at Gly-90 in the second transmembrane helix of the photoreceptor protein rhodopsin have been proposed to lead to different phenotypes. G90D has been classically associated with congenital night blindness, whereas the newly reported G90V substitution was linked to a retinitis pigmentosa phenotype. Here, we used Val/Asp replacements of the native Gly at position 90 to unravel the structure/function divergences caused by these mutations and the potential molecular mechanisms of inherited retinal disease. The G90V and G90D mutants have a similar conformation around the Schiff base linkage region in the dark state and same regeneration kinetics with 11-cis-retinal, but G90V has dramatically reduced thermal stability when compared with the G90D mutant rhodopsin. The G90V mutant also shows, like G90D, an altered photobleaching pattern and capacity to activate Gt in the opsin state. Furthermore, the regeneration of the G90V mutant with 9-cis-retinal was improved, achieving the same A(280)/A(500) as wild type isorhodopsin. Hydroxylamine resistance was also recovered, indicating a compact structure around the Schiff base linkage, and the thermal stability was substantially improved when compared with the 11-cis-regenerated mutant. These results support the role of thermal instability and/or abnormal photoproduct formation in eliciting a retinitis pigmentosa phenotype. The improved stability and more compact structure of the G90V mutant when it was regenerated with 9-cis-retinal brings about the possibility that this isomer or other modified retinoid analogues might be used in potential treatment strategies for mutants showing the same structural features.

MeSH Terms
Amino Acid Substitution Animals COS Cells Cattle Cell Line, Tumor Diterpenes Eye Diseases, Hereditary Genetic Diseases, X-Linked Humans Mutation, Missense Myopia/genetics,metabolism Night Blindness/genetics,metabolism Protein Stability Protein Structure, Tertiary Retinaldehyde/genetics,metabolism Retinitis Pigmentosa/genetics,metabolism Rhodopsin/genetics,metabolism Structure-Activity Relationship
Chemicals
Diterpenes 9-cis-retinal Rhodopsin Retinaldehyde
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Toledo Darwin
Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.
Ramon Eva
Aguilà Mònica
Cordomí Arnau
Pérez Juan J
Mendes Hugo F
Cheetham Michael E
Garriga Pere
Supplementary Concepts
Night blindness, congenital stationary (Disease)
References (52)
52 references, click to expand
  1. [Rhodopsin structure: some light into the shadows of retinal degenerations].
    Med Clin (Barc). 2003 Jun 28;121(4):153-7 PMID: 12867022
  2. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1630-5 PMID: 16565402
  3. Structure and function in rhodopsin. Measurement of the rate of metarhodopsin II decay by fluorescence spectroscopy.
    J Biol Chem. 1995 Mar 10;270(10):5073-6 PMID: 7890614
  4. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa.
    Invest Ophthalmol Vis Sci. 2000 May;41(6):1546-53 PMID: 10798675
  5. The role of transmembrane segment II in 7TM receptor activation.
    Curr Mol Pharmacol. 2009 Jun;2(2):140-8 PMID: 20021454
  6. Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation.
    Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):880-4 PMID: 7846071
  7. Characterization of rhodopsin congenital night blindness mutant T94I.
    Biochemistry. 2003 Feb 25;42(7):2009-15 PMID: 12590588
  8. Structural models of class a G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticity.
    Curr Top Med Chem. 2007;7(10):991-8 PMID: 17508932
  9. Night blindness and the mechanism of constitutive signaling of mutant G90D rhodopsin.
    J Neurosci. 2008 Nov 5;28(45):11662-72 PMID: 18987202
  10. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems.
    Nucleic Acids Res. 2001 Jan 1;29(1):346-9 PMID: 11125133
  11. Covalent bond between ligand and receptor required for efficient activation in rhodopsin.
    J Biol Chem. 2010 Mar 12;285(11):8114-21 PMID: 20042594
  12. Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa.
    Proc Natl Acad Sci U S A. 1996 May 14;93(10):4554-9 PMID: 8643442
  13. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue.
    J Mol Biol. 2010 Feb 5;395(5):1063-78 PMID: 19913029
  14. Altered functionality in rhodopsin point mutants associated with retinitis pigmentosa.
    Biochem Biophys Res Commun. 2003 Mar 28;303(1):294-301 PMID: 12646201
  15. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8840-4 PMID: 1924344
  16. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system.
    J Biol Chem. 2002 Sep 13;277(37):34150-60 PMID: 12091393
  17. Modulating rhodopsin receptor activation by altering the pKa of the retinal Schiff base.
    J Am Chem Soc. 2006 Aug 16;128(32):10503-12 PMID: 16895417
  18. Protein misfolding and human disease.
    Annu Rev Genomics Hum Genet. 2006;7:103-24 PMID: 16722804
  19. Isorhodopsin rather than rhodopsin mediates rod function in RPE65 knock-out mice.
    Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13662-7 PMID: 14578454
  20. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3551-5 PMID: 7724596
  21. The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.
    Annu Rev Biophys Biomol Struct. 2003;32:375-97 PMID: 12574068
  22. Constitutive excitation by Gly90Asp rhodopsin rescues rods from degeneration caused by elevated production of cGMP in the dark.
    J Neurosci. 2007 Aug 15;27(33):8805-15 PMID: 17699662
  23. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94 --> Ile.
    J Biol Chem. 2003 Feb 21;278(8):6427-32 PMID: 12466267
  24. Retinal counterion switch in the photoactivation of the G protein-coupled receptor rhodopsin.
    Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9262-7 PMID: 12835420
  25. Protein assistance in the photoisomerization of rhodopsin and 9-cis-rhodopsin--insights from experiment and theory.
    J Am Chem Soc. 2007 Feb 7;129(5):1052-4 PMID: 17263385
  26. Cell toxicity and conformational disease.
    Trends Cell Biol. 2005 Nov;15(11):574-80 PMID: 16202603
  27. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation.
    J Cell Sci. 2002 Jul 15;115(Pt 14):2907-18 PMID: 12082151
  28. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):8874-8 PMID: 2962193
  29. Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8309-13 PMID: 2573063
  30. Opsin activation as a cause of congenital night blindness.
    Nat Neurosci. 2003 Jul;6(7):731-5 PMID: 12778053
  31. Effect of carboxylic acid side chains on the absorption maximum of visual pigments.
    Science. 1989 Nov 17;246(4932):928-30 PMID: 2573154
  32. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa.
    Biochemistry. 1994 May 24;33(20):6121-8 PMID: 8193125
  33. Slow binding of retinal to rhodopsin mutants G90D and T94D.
    Biochemistry. 2003 Feb 25;42(7):2002-8 PMID: 12590587
  34. Structure and function in rhodopsin: Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4872-6 PMID: 11320236
  35. Stability of dark state rhodopsin is mediated by a conserved ion pair in intradiscal loop E-2.
    J Biol Chem. 2003 May 9;278(19):16982-91 PMID: 12547830
  36. Characterization of the mutant visual pigment responsible for congenital night blindness: a biochemical and Fourier-transform infrared spectroscopy study.
    Biochemistry. 1996 Jun 11;35(23):7536-45 PMID: 8652533
  37. Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa.
    Hum Mol Genet. 2008 Oct 1;17(19):3043-54 PMID: 18635576
  38. Role of the intradiscal domain in rhodopsin assembly and function.
    Proc Natl Acad Sci U S A. 1990 Jul;87(13):4991-5 PMID: 2367520
  39. Comparison of multiple Amber force fields and development of improved protein backbone parameters.
    Proteins. 2006 Nov 15;65(3):712-25 PMID: 16981200
  40. Two protonation switches control rhodopsin activation in membranes.
    Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17795-800 PMID: 18997017
  41. A dual role for EDEM1 in the processing of rod opsin.
    J Cell Sci. 2009 Dec 15;122(Pt 24):4465-72 PMID: 19934218
  42. G protein-coupled receptor rhodopsin.
    Annu Rev Biochem. 2006;75:743-67 PMID: 16756510
  43. Conformational diseases: looking into the eyes.
    Brain Res Bull. 2010 Jan 15;81(1):12-24 PMID: 19808079
  44. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.
    Trends Mol Med. 2005 Apr;11(4):177-85 PMID: 15823756
  45. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa.
    J Biol Chem. 2003 Apr 18;278(16):14442-14450 PMID: 12566452
  46. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H.
    J Biol Chem. 2004 Apr 16;279(16):16278-84 PMID: 14769795
  47. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness.
    Nature. 1994 Feb 17;367(6464):639-42 PMID: 8107847
  48. Alterations in the photoactivation pathway of rhodopsin mutants associated with retinitis pigmentosa.
    FEBS J. 2011 May;278(9):1493-505 PMID: 21352497
  49. 1 rhodopsin mutations in congenital night blindness.
    Adv Exp Med Biol. 2010;664:263-72 PMID: 20238025
  50. Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
    Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6481-5 PMID: 1862076
  51. Identification and functional characterization of a novel rhodopsin mutation associated with autosomal dominant CSNB.
    Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4105-14 PMID: 18487375
  52. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness.
    Nat Genet. 1993 Jul;4(3):280-3 PMID: 8358437
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2011-11-18
Epub
2011-00-22
Pages
39993-40001
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC3220564
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com